Jeff D. Edelson
Directeur Technique/Scientifique/R&D chez BioMotiv LLC
Provenance du réseau au premier degré de Jeff D. Edelson
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Ikano Therapeutics, Inc.
 Ikano Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ikano Therapeutics Inc. (ITI) is a specialty pharmaceutical company focused on developing innovative therapeutics, with an emphasis on products treating disorders related to the central nervous system (CNS) for which there is proven, unsatisfied consumer need. They currently have two products in its clinical pipeline, with and others in formulation or preclinical development. Its goal is to become a leader in the field of specialty pharmaceuticals by applying its formulation expertise across a broad range of therapeutic areas to create new and differentiated products that improve safety, efficacy and convenience for patients, caregivers and health care professionals. ITI's fully integrated drug delivery platform combines proprietary formulation research, clinical and regulatory development, specialized delivery systems, clinical manufacturing and packaging. These capabilities and expertise enable them to develop its products efficiently and cost effectively. They intend to commercialize these products by marketing them themselves or partnering them with other companies. Its senior management team collectively has more than 100 years of experience in the pharmaceutical industry and extensive experience with development-stage companies. ITI supplements its own internal expertise with a variety of outside expert consultants, academic and industry and makes strategic use of outsourcing for development and commercial manufacturing.
12
| Extinct | Pharmaceuticals: Major | 12 |
BioMotiv LLC
 BioMotiv LLC BiotechnologyHealth Technology BioMotiv LLC operates as a research institution in the field of therapeutics. It focuses in disease areas and classes of therapeutics such as small molecules, antibodies, proteins, and nucleotides. The company was founded on September 10, 2012 and is headquartered in Cleveland, OH.
10
| Subsidiary | Biotechnology | 10 |
| Public Company | Pharmaceuticals: Major | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jeff D. Edelson via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| EMISPHERE TECHNOLOGIES, INC. | Pharmaceuticals: Major | President | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| DERMA SCIENCES INC | Medical Specialties | Chief Tech/Sci/R&D Officer | |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ORAGENICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ActivBiotics, Inc.
 ActivBiotics, Inc. BiotechnologyHealth Technology ActivBiotics, Inc. discovers and develops pharmaceutical drugs. It provides discovery, development, and commercialization of therapies for the treatment of vascular disease, inflammation, and other high-value chronic and infectious diseases. The company was founded in 1996 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Janssen-Cilag International NV
 Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Biotechnology | Chairman | |
| CORMEDIX INC. | Biotechnology | Director/Board Member | |
Cytogel Pharma LLC
 Cytogel Pharma LLC BiotechnologyHealth Technology Cytogel Pharma LLC develops bio-pharmaceutical products. It offers novel analgesic products, useful polymer and hydrogel drug delivery platform technologies. The company was founded in 2002 and is headquartered in Darien, CT. | Biotechnology | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
| BOTANIX PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| BIONOMICS LIMITED | Pharmaceuticals: Generic | Chairman Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BIO 101, Inc.
 BIO 101, Inc. Medical SpecialtiesHealth Technology Part of Valiant Co., Ltd., BIO 101, Inc. is a company that develops DNA and RNA purification kits and laboratory tools. The company is based in Carlsbad, CA. BIO 101 was acquired by Quantum Biotechnologies USA on April 05, 2000. | Medical Specialties | Director/Board Member | |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Investment Managers | Private Equity Investor | |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Pharmaceuticals: Major | Director/Board Member | |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Indiana University | College/University | Undergraduate Degree | |
| State University of New York at Buffalo | College/University | Undergraduate Degree | |
AlphaVax, Inc.
 AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Pharmaceuticals: Major | President | |
NC Life Sciences Organization
 NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chairman | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Director/Board Member Director of Finance/CFO | |
| National Association of Pharmaceutical Manufacturers | Founder | ||
| Danerius LLC | Founder | ||
Sancilio & Co., Inc.
 Sancilio & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio & Co., Inc. operates as specialty pharmaceutical company. It develops and markets based products including those based on the proprietary Advanced Lipid Technologies platform. The company was founded by Frederick D. Sancilio in 2005 and is headquartered in Riviera Beach, FL. | Miscellaneous Commercial Services | Director/Board Member | |
| Abbott International LLC | Corporate Officer/Principal | ||
| Johnson & Johnson Pharmaceutical Group | Corporate Officer/Principal | ||
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| Richardson-Merrell | Sales & Marketing | ||
| Davis-Edwards Pharmacal Corp. | Founder | ||
PanOptica, Inc.
 PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ELECTROCORE, INC. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Summit Biosciences, Inc.
 Summit Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Summit Biosciences, Inc. develops, manufactures, and commercializes nasal spray drug products. Its services include formulation development, contract manufacturing of commercial and clinical products, spray characterization, and analytical development and validation. The company was founded by Edwin A. Cohen in 2008 and is headquartered in Lexington, KY. | Pharmaceuticals: Major | Chief Executive Officer | |
Navigen, Inc.
 Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT. | Pharmaceuticals: Major | Director/Board Member | |
| Kelley School of Business | College/University | Masters Business Admin | |
| RECCE PHARMACEUTICALS LTD | Pharmaceuticals: Major | Director/Board Member | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
DepYmed, Inc.
 DepYmed, Inc. BiotechnologyHealth Technology DepYmed , Inc. is a cancer and rare disease therapeutic development company. The company is headquartered in Farmingdale, NY. | Biotechnology | Director/Board Member | |
Purdue Pharmaceuticals LP
 Purdue Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Part of Purdue Pharma LP, Purdue Pharmaceuticals LP is a physician-founded and physician-led company that develops, manufactures, and markets medications and consumer health products. Purdue Pharmaceuticals is based in Wilson, NC and offers a diverse product line. The company is committed to supporting collaborations to drive innovations in patient care while addressing the opioid addiction crisis. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Pharmaceuticals: Major | Director/Board Member | |
| ADHERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| New York University School of Medicine | College/University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 46 |
| Australie | 5 |
| Belgique | 2 |
Sectorielle
| Health Technology | 33 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 196 |
| Corporate Officer/Principal | 56 |
| Independent Dir/Board Member | 43 |
| Chairman | 38 |
| Chief Executive Officer | 26 |
Relations les plus connectées
| Insiders | |
|---|---|
| Michael Ross | 44 |
| G. Steven Burrill | 44 |
| Robert Mark Weisskoff | 34 |
| Alan Dunton | 34 |
| James Tullis | 32 |
| Bruce Peacock | 28 |
| Errol de Souza | 21 |
| Michael Martin | 17 |
| Peter Young | 15 |
| Patrick Fabbio | 13 |
| Angela Rossetti | 11 |
| Trevor Hallam | 10 |
| Michael E. Lusty | 9 |
| Edwin A. Cohen | 8 |
| Timothy I. Mitchell | 8 |
- Bourse
- Insiders
- Jeff D. Edelson
- Connexions Sociétés
